114 related articles for article (PubMed ID: 37994899)
1. Sialic Acid-Modified O-GlcNAc Transferase Inhibitor Liposome Presents Antitumor Effect in Hepatocellular Carcinoma.
Lin B; Chai S; Zhang Q; Lu Y; Hu J; Zhang J; Du YZ; Wu L
Mol Pharm; 2024 Jan; 21(1):102-112. PubMed ID: 37994899
[TBL] [Abstract][Full Text] [Related]
2. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.
Zhu Q; Zhou L; Yang Z; Lai M; Xie H; Wu L; Xing C; Zhang F; Zheng S
Med Oncol; 2012 Jun; 29(2):985-93. PubMed ID: 21461968
[TBL] [Abstract][Full Text] [Related]
3. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.
Cao B; Duan M; Xing Y; Liu C; Yang F; Li Y; Yang T; Wei Y; Gao Q; Jiang J
J Cell Mol Med; 2019 Apr; 23(4):2384-2398. PubMed ID: 30677218
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress.
Xu W; Zhang X; Wu JL; Fu L; Liu K; Liu D; Chen GG; Lai PB; Wong N; Yu J
J Hepatol; 2017 Aug; 67(2):310-320. PubMed ID: 28347804
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis.
Duan F; Wu H; Jia D; Wu W; Ren S; Wang L; Song S; Guo X; Liu F; Ruan Y; Gu J
J Hepatol; 2018 Jun; 68(6):1191-1202. PubMed ID: 29454068
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAcylation of histone deacetylases 1 in hepatocellular carcinoma promotes cancer progression.
Zhu G; Tao T; Zhang D; Liu X; Qiu H; Han L; Xu Z; Xiao Y; Cheng C; Shen A
Glycobiology; 2016 Aug; 26(8):820-833. PubMed ID: 27060025
[TBL] [Abstract][Full Text] [Related]
7. Identification of a diketopiperazine-based O-GlcNAc transferase inhibitor sensitizing hepatocellular carcinoma to CDK9 inhibition.
Shan X; Jiang R; Gou D; Xiang J; Zhou P; Xia J; Wang K; Huang A; Tang N; Huang L
FEBS J; 2023 Sep; 290(18):4543-4561. PubMed ID: 37247228
[TBL] [Abstract][Full Text] [Related]
8. OSMI-1 Enhances TRAIL-Induced Apoptosis through ER Stress and NF-κB Signaling in Colon Cancer Cells.
Lee SJ; Lee DE; Choi SY; Kwon OS
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681736
[TBL] [Abstract][Full Text] [Related]
9. The positive feedback between ACSL4 expression and O-GlcNAcylation contributes to the growth and survival of hepatocellular carcinoma.
Wang J; Wang Z; Yuan J; Wang J; Shen X
Aging (Albany NY); 2020 May; 12(9):7786-7800. PubMed ID: 32357142
[TBL] [Abstract][Full Text] [Related]
10. Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.
Wang F; He L; Dai WQ; Xu YP; Wu D; Lin CL; Wu SM; Cheng P; Zhang Y; Shen M; Wang CF; Lu J; Zhou YQ; Xu XF; Xu L; Guo CY
PLoS One; 2012; 7(12):e50638. PubMed ID: 23284640
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of OGT by Caveolin-1 promotes hepatocellular carcinoma cell migration and invasion.
Wang L; Feng Y; Zhang C; Chen X; Huang H; Li W; Zhang J; Liu Y
Cell Biol Int; 2021 Nov; 45(11):2251-2263. PubMed ID: 34288245
[TBL] [Abstract][Full Text] [Related]
12. P53 suppresses the progression of hepatocellular carcinoma via miR-15a by decreasing OGT expression and EZH2 stabilization.
You Z; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X
J Cell Mol Med; 2021 Oct; 25(19):9168-9182. PubMed ID: 34510715
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAcylation promotes the migratory ability of hepatocellular carcinoma cells via regulating FOXA2 stability and transcriptional activity.
Huang H; Wu Q; Guo X; Huang T; Xie X; Wang L; Liu Y; Shi L; Li W; Zhang J; Liu Y
J Cell Physiol; 2021 Nov; 236(11):7491-7503. PubMed ID: 33843053
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylserine and/or Sialic Acid Modified Liposomes Increase Uptake by Tumor-associated Macrophages and Enhance the Anti-tumor Effect.
Xu Z; Li J; Yan N; Liu X; Deng Y; Song Y
AAPS PharmSciTech; 2024 Jun; 25(5):125. PubMed ID: 38834759
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAc Transferase Inhibitor Synergistically Enhances Doxorubicin-Induced Apoptosis in HepG2 Cells.
Lee SJ; Kwon OS
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33121131
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N
Yang Y; Yan Y; Yin J; Tang N; Wang K; Huang L; Hu J; Feng Z; Gao Q; Huang A
Signal Transduct Target Ther; 2023 Feb; 8(1):63. PubMed ID: 36765030
[TBL] [Abstract][Full Text] [Related]
17. O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis.
Liu R; Gou D; Xiang J; Pan X; Gao Q; Zhou P; Liu Y; Hu J; Wang K; Tang N
Oncogene; 2021 Dec; 40(50):6707-6719. PubMed ID: 34650217
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAcylation of SIX1 enhances its stability and promotes Hepatocellular Carcinoma Proliferation.
Chu Y; Jiang M; Wu N; Xu B; Li W; Liu H; Su S; Shi Y; Liu H; Gao X; Fu X; Chen D; Li X; Wang W; Liang J; Nie Y; Fan D
Theranostics; 2020; 10(21):9830-9842. PubMed ID: 32863962
[TBL] [Abstract][Full Text] [Related]
19. Hexosamine Biosynthetic Pathway-Derived O-GlcNAcylation Is Critical for RANKL-Mediated Osteoclast Differentiation.
Kim MJ; Kim HS; Lee S; Min KY; Choi WS; You JS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445596
[TBL] [Abstract][Full Text] [Related]
20. Release of O-GlcNAc transferase inhibitor promotes neuronal differentiation of neural stem cells in 3D bioprinted supramolecular hydrogel scaffold for spinal cord injury repair.
Liu X; Song S; Chen Z; Gao C; Li Y; Luo Y; Huang J; Zhang Z
Acta Biomater; 2022 Oct; 151():148-162. PubMed ID: 36002129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]